Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL) (Middle Region) Peptid

BNIPL Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN8095478
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL) (Middle Region) Peptid (ABIN8095478)

Target

BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Verwendungszweck

    BNIPL Peptide - middle region

    Sequenz

    AENYLLVHLS GGTSRAQVPP LSWIRQCYRT LDRRLRKNLR ALVVVHATWY
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-BNIPL Antibody(ARP52577_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    BNIPL (BCL2/adenovirus E1B 19kD Interacting Protein Like (BNIPL))

    Hintergrund

    Background Information: BNIPL may be a bridge molecule between BCL2 and ARHGAP1/CDC42 in promoting cell death.

    Alternative Symbols: BNIP-S, BNIPL-1, BNIPL-2, PP753

    Molekulargewicht

    40kDa

    Gen-ID

    149428

    NCBI Accession

    NP_612122

    UniProt

    Q7Z465
Sie sind hier:
Chat with us!